Data / Form D filings / Chroma Medicine, Inc.
Chroma Medicine, Inc.: Form D filings
Chroma Medicine, Inc., a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC in 2023. The latest, on September 1, 2023, reports $135 million sold of a $135 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 BROOKLINE AVE, SUITE 1101, Boston, MA, 02215
- Phone
- (617) 714-5547
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1967386
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Amendment | $135,000,000 | $135,000,000 | 21 | Feb 8, 2023 | sec.gov | |
| Mar 1, 2023 | New notice | $135,000,000 | $135,000,000 | 21 | Feb 8, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BIHUA CHEN | Director | |
| GEORGE GOLUMBESKI | Director | |
| KEVIN BITTERMAN | Director | |
| BRETT KAPLAN | Executive Officer | |
| VIC MYER | Executive Officer | |
| MICHAEL KELLY | Director | |
| CATHERINE STEHMAN-BREEN | Executive Officer, Director | |
| PAOLA POZZI | Director | |
| JEFF MARRAZZO | Director | |
| THOMAS CAHILL | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 28, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Chroma Medicine, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.